BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3216687)

  • 1. [Serum CA 125 and ferritin in patients with ovarian carcinoma].
    Kanajet D; Klarić P; Filjak K
    Jugosl Ginekol Perinatol; 1988; 28(5-6):125-8. PubMed ID: 3216687
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of serum determinations of CA125, CA15-3 and CA50 in the preoperative evaluation of adnexal tumors].
    Gadducci A; Facchini V; Ferdeghini M; Ceccarini T; Bartolini T; Fontana V; Bianchi R; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1988; 109(4):199-204. PubMed ID: 3232907
    [No Abstract]   [Full Text] [Related]  

  • 3. [CA 125, a marker of ovarian epithelial tumors].
    Ruibal A
    Med Clin (Barc); 1988 Jun; 91(2):54-7. PubMed ID: 3050307
    [No Abstract]   [Full Text] [Related]  

  • 4. Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?
    Sevelda P; Rosen A; Denison U; Barrada M; Spona J; Salzer H
    Gynecol Oncol; 1991 Nov; 43(2):154-8. PubMed ID: 1743558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of serum ferritin in female genital neoplasms].
    Dong MY
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of serum CASA and CA 125 levels in patients with ovarian carcinoma.
    Meisel M; Straube W; Weise J; Burkhardt B
    Arch Gynecol Obstet; 1995; 256(1):9-15. PubMed ID: 7726659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A CA 12-5 prognostic score for epithelial ovarian cancers].
    Klein M; Rosen A; Sevelda P; Spona J; Beck A
    Gynakol Rundsch; 1990; 30 Suppl 1():70-2. PubMed ID: 2079305
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumor markers in epithelial carcinoma of the ovary].
    Cottini M; Carnino F; Iskra L; Rapisarda V; Mossetti C
    Minerva Ginecol; 1986 Jun; 38(6):479-84. PubMed ID: 3461313
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperferritinemia in ovarian cancer.
    Yuan CC; Ng HT; Yeh SH; Chen SS; Hsu DS; Ho CH
    J Reprod Med; 1988 Feb; 33(2):193-5. PubMed ID: 3351817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum copper in ovarian carcinoma.
    Jacobs AJ; Sommers GM; Axelrod JH; Galakatos AE; Kao MS; Camel HM
    Cancer; 1988 Mar; 61(5):1015-7. PubMed ID: 3422179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The dosage of CA 125 in carcinoma of the ovary and other solid neoplasms].
    Scheinberg MA; Baracat F; Nunes AP; Murakami S
    Rev Paul Med; 1988; 106(3):145-6. PubMed ID: 2471993
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of preoperative serum CA-125 to survival in epithelial ovarian carcinoma.
    Geisler JP; Miller GA; Lee TH; Harwood RM; Wiemann MC; Geisler HE
    J Reprod Med; 1996 Mar; 41(3):140-2. PubMed ID: 8778409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas.
    Ryuko K; Iwanari O; Kitao M; Moriwaki S
    Gynecol Oncol; 1993 May; 49(2):215-24. PubMed ID: 8504990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum CA 125 level allows early identification of nonresponders during induction chemotherapy.
    Makar AP; Kristensen GB; Børmer OP; Tropé CG
    Gynecol Oncol; 1993 Apr; 49(1):73-9. PubMed ID: 8482563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer].
    Gadducci A; Ferdeghini M; Bartolini T; Facchini V; Bianchi R; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1986; 107(4):193-9. PubMed ID: 3467641
    [No Abstract]   [Full Text] [Related]  

  • 16. Is serum CA 125 at the time of relapse a prognostic indicator for further survival prognosis in patients with ovarian cancer?
    Makar AP; Kristensen GB; Børmer OP; Tropé CG
    Gynecol Oncol; 1993 Apr; 49(1):3-7. PubMed ID: 8482556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
    Göcze P; Vahrson H
    Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoradiometric assay for CA125 in monitoring the course of epithelial ovarian cancer.
    Tommasi M; Cappelli G; Fantappiè B; Cefaratti C; Bonazza M; Branconi F
    J Nucl Med Allied Sci; 1986; 30(1):45-50. PubMed ID: 3462354
    [No Abstract]   [Full Text] [Related]  

  • 19. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
    Harłozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R
    Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative value of CA 125 as a reflection of tumor grade in epithelial ovarian cancer.
    But I; Gorisek B
    Gynecol Oncol; 1996 Nov; 63(2):166-72. PubMed ID: 8910622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.